ApelinBiomarker1 paperHumans1LatestNov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 3Oct 2026: 03BiomedicinesAnimals·26 SepApelin-13 Pretreatment Attenuates Age-Associated Renal Fibrotic Remodeling Following I/R InjuryKidneynpj AgingHumans·18 SepValidation and refinement of a biomarker panel for frailty assessment and prediction of muscle weakness in older adultsBiomarkersNature Reviews Drug DiscoveryReview·8 SepStrengthening muscle for healthy ageing: innovative treatments for sarcopeniaSarcopeniaADA Scientific Sessions 2025 AbstractAnimals·13 JunThe Apelin Receptor Agonist Azelaprag Shows Cardioprotective Effects as Monotherapy and Enhanced Benefits with Semaglutide in a Diet-Induced Obesity Model of Heart Failure with Preserved Ejection FractionInterventions
BiomedicinesAnimals·26 SepApelin-13 Pretreatment Attenuates Age-Associated Renal Fibrotic Remodeling Following I/R InjuryKidney
npj AgingHumans·18 SepValidation and refinement of a biomarker panel for frailty assessment and prediction of muscle weakness in older adultsBiomarkers
Nature Reviews Drug DiscoveryReview·8 SepStrengthening muscle for healthy ageing: innovative treatments for sarcopeniaSarcopenia
ADA Scientific Sessions 2025 AbstractAnimals·13 JunThe Apelin Receptor Agonist Azelaprag Shows Cardioprotective Effects as Monotherapy and Enhanced Benefits with Semaglutide in a Diet-Induced Obesity Model of Heart Failure with Preserved Ejection FractionInterventions